A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular Carcinoma

By afschroeder • May 9, 2026

Taggart DJ, Mahajan S, Gallant MA, Pinkoviezky I, Xu J, Sorg AJ, Roberts CC, Slinkov D, Gorospe EC, Mubarak A, Bhandari BR, Freilich B, Gunn N, Yang JD, Smith JH, Younes ZH, Cabrera R, Aguilar H, Samant H, Li W, Van Etten RA, Nguyen MH. A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular Carcinoma. J Hepatol. 2026 May 6:S0168-8278(26)00215-1. doi: 10.1016/j.jhep.2026.04.012. Epub ahead of print. PMID: 42102976.

Tags: Cancer biomarkers, Cedars Sinai DoM, cell-free DNA, Digestive Diseases, DNA methylation, Early cancer detection, Hepatocellular carcinoma, liver cancer, Publications

Related Posts

Let distortion-guided restoration: a physics-informed learning framework to correct prostate diffusion MRI artifacts

Long Z, Binesh N, Wang L, Malaji AV, Yang CC, Sun H, Saouaf R, Daskivich T, Kim H, Xie Y, Li D, Yang HJ. Let[...]

Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial

McDonald CM, Villa C, Soslow JH, Maharry K, Hogan N, Binks M, Berth KC, Elliott KA, Taylor M, Hor KN, Signorovich J, Henricson EK, Phan[...]

Hidden risk in normal myocardial perfusion scans: AI-detected proximal coronary calcium on CT attenuation maps improves prognosis

Zhou J, Miller RJH, Shanbhag A, Killekar A, Han D, Patel KK, Pieszko K, Yi J, Urs MK, Ramirez G, Lemley M, Kavanagh PB, Liang[...]